Tag Archives: PDUSFA

New Funding and Approval Pathways Prove Popular

By Rita Peters, Editorial Director, BioPharm International. Compared to other manufacturing and technology industries, the bio/pharmaceutical industry has one of the longest product developmentĀ timelines. The research, development, testing, and regulatory review process typically extends for more than a decade, often exhausting the financial resources and commitment of investors. For patients with unmet medical needs, the […]
Posted in Biotech, FDA, Guest Blog, Regulatory | Also tagged , , , , , | Leave a comment
  • Categories

  • Meta